![D5U D5U](https://data.pdbj.org/pdbjplus/data/cc/svg/D5U.svg) | D5U | Name: | 2-[3-(2-methoxyphenyl)-3-oxidanylidene-propyl]benzoic acid | Formula: | C17 H16 O4 | SMILES: | COc1ccccc1C(=O)CCc2ccccc2C(O)=O | InChi: | InChI=1S/C17H16O4/c1-21-16-9-5-4-8-14(16)15(18)11-10-12-6-2-3-7-13(12)17(19)20/h2-9H,10-11H2,1H3,(H,19,20) | Definition date: | 2019-07-04 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2-[3-(2-methoxyphenyl)-3-oxidanylidene-propyl]benzoic acid |
|
![D60 D60](https://data.pdbj.org/pdbjplus/data/cc/svg/D60.svg) | D60 | Name: | 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid | Formula: | C23 H18 F2 N4 O3 | SMILES: | Cn1cc(cn1)c2ccc(C(O)=O)c(CCC(=O)c3c(F)cc(cc3F)c4c[nH]nc4)c2 | InChi: | InChI=1S/C23H18F2N4O3/c1-29-12-17(11-28-29)13-2-4-18(23(31)32)14(6-13)3-5-21(30)22-19(24)7-15(8-20(22)25)16-9-26-27-10-16/h2,4,6-12H,3,5H2,1H3,(H,26,27)(H,31,32) | Definition date: | 2019-07-04 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid |
|
![KDZ KDZ](https://data.pdbj.org/pdbjplus/data/cc/svg/KDZ.svg) | KDZ | Name: | (3~{R})-2,2-bis(oxidanyl)-3-(phenylmethylsulfanyl)-3,4-dihydro-1,2-benzoxaborinin-2-ium-8-carboxylic acid | Formula: | C16 H16 B O5 S | SMILES: | OC(=O)c1cccc2C[CH](SCc3ccccc3)[B-](O)(O)Oc12 | InChi: | InChI=1S/C16H16BO5S/c18-16(19)13-8-4-7-12-9-14(17(20,21)22-15(12)13)23-10-11-5-2-1-3-6-11/h1-8,14,20-21H,9-10H2,(H,18,19)/q-1/t14-/m0/s1 | Definition date: | 2019-05-14 | Last modified: | 2020-04-09 | Release date: | 2020-03-25 | Identifier: | (4~{R})-3,3-bis(oxidanyl)-4-(phenylmethylsulfanyl)-2-oxa-3-boranuidabicyclo[4.4.0]deca-1(6),7,9-triene-10-carboxylic acid |
|
![KL8 KL8](https://data.pdbj.org/pdbjplus/data/cc/svg/KL8.svg) | KL8 | Name: | (3~{S})-2,2-bis(oxidanyl)-3-(phenylmethylsulfanyl)-3,4-dihydro-1,2-benzoxaborinin-2-ium-8-carboxylic acid | Formula: | C16 H16 B O5 S | SMILES: | OC(=O)c1cccc2C[CH](SCc3ccccc3)[B-](O)(O)Oc12 | InChi: | InChI=1S/C16H16BO5S/c18-16(19)13-8-4-7-12-9-14(17(20,21)22-15(12)13)23-10-11-5-2-1-3-6-11/h1-8,14,20-21H,9-10H2,(H,18,19)/q-1/t14-/m1/s1 | Definition date: | 2019-06-04 | Last modified: | 2020-04-09 | Release date: | 2020-03-25 | Identifier: | (4~{S})-3,3-bis(oxidanyl)-4-(phenylmethylsulfanyl)-2-oxa-3-boranuidabicyclo[4.4.0]deca-1(6),7,9-triene-10-carboxylic acid |
|
![3CK 3CK](https://data.pdbj.org/pdbjplus/data/cc/svg/3CK.svg) | 3CK | Name: | beta-D-tagatofuranosyl alpha-D-glucopyranoside | Formula: | C12 H22 O11 | SMILES: | O1C(CO)C(O)C(O)C(O)C1OC2(OC(C(O)C2O)CO)CO | InChi: | InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7+,8+,9-,10+,11-,12+/m1/s1 | Definition date: | 2014-07-28 | Last modified: | 2020-04-08 | Release date: | 2014-08-06 | Identifier: | beta-D-tagatofuranosyl alpha-D-glucopyranoside |
|
![29E 29E](https://data.pdbj.org/pdbjplus/data/cc/svg/29E.svg) | 29E | Name: | (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine | Formula: | C18 H19 N O S | SMILES: | O(c1cccc2c1cccc2)C(c3sccc3)CCNC | InChi: | InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1 | Synonyms: | Duloxetine | Definition date: | 2013-09-11 | Last modified: | 2020-04-05 | Release date: | 2013-10-16 | Identifier: | (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
|
![MZN MZN](https://data.pdbj.org/pdbjplus/data/cc/svg/MZN.svg) | MZN | Name: | 7-(2-fluoranyl-6-oxidanyl-phenyl)-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-2,6-naphthyridin-1-one | Formula: | C21 H20 F N3 O3 | SMILES: | CCC(=O)N1CC[CH](C1)C2=NC(=O)c3cc(ncc3C2)c4c(O)cccc4F | InChi: | InChI=1S/C21H20FN3O3/c1-2-19(27)25-7-6-12(11-25)16-8-13-10-23-17(9-14(13)21(28)24-16)20-15(22)4-3-5-18(20)26/h3-5,9-10,12,26H,2,6-8,11H2,1H3/t12-/m1/s1 | Definition date: | 2019-10-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 7-(2-fluoranyl-6-oxidanyl-phenyl)-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-2,6-naphthyridin-1-one |
|
![MZQ MZQ](https://data.pdbj.org/pdbjplus/data/cc/svg/MZQ.svg) | MZQ | Name: | 7-[2,4-bis(fluoranyl)phenyl]-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-isoquinolin-1-one | Formula: | C22 H20 F2 N2 O2 | SMILES: | CCC(=O)N1CC[CH](C1)C2=NC(=O)c3cc(ccc3C2)c4ccc(F)cc4F | InChi: | InChI=1S/C22H20F2N2O2/c1-2-21(27)26-8-7-15(12-26)20-10-14-4-3-13(9-18(14)22(28)25-20)17-6-5-16(23)11-19(17)24/h3-6,9,11,15H,2,7-8,10,12H2,1H3/t15-/m1/s1 | Definition date: | 2019-10-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 7-[2,4-bis(fluoranyl)phenyl]-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-isoquinolin-1-one |
|
![JQE JQE](https://data.pdbj.org/pdbjplus/data/cc/svg/JQE.svg) | JQE | Name: | 2-[2,5-bis(chloranyl)-1-benzothiophen-3-yl]ethanoic acid | Formula: | C10 H6 Cl2 O2 S | SMILES: | OC(=O)Cc1c(Cl)sc2ccc(Cl)cc12 | InChi: | InChI=1S/C10H6Cl2O2S/c11-5-1-2-8-6(3-5)7(4-9(13)14)10(12)15-8/h1-3H,4H2,(H,13,14) | Definition date: | 2019-03-20 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 2-[2,5-bis(chloranyl)-1-benzothiophen-3-yl]ethanoic acid |
|
![JQW JQW](https://data.pdbj.org/pdbjplus/data/cc/svg/JQW.svg) | JQW | Name: | 4-[6,7-bis(chloranyl)-1~{H}-indol-3-yl]pyrimidin-2-amine | Formula: | C12 H8 Cl2 N4 | SMILES: | Nc1nccc(n1)c2c[nH]c3c(Cl)c(Cl)ccc23 | InChi: | InChI=1S/C12H8Cl2N4/c13-8-2-1-6-7(5-17-11(6)10(8)14)9-3-4-16-12(15)18-9/h1-5,17H,(H2,15,16,18) | Definition date: | 2019-03-21 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 4-[6,7-bis(chloranyl)-1~{H}-indol-3-yl]pyrimidin-2-amine |
|
![QPV QPV](https://data.pdbj.org/pdbjplus/data/cc/svg/QPV.svg) | QPV | Name: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide | Formula: | C21 H23 Cl N2 O2 | SMILES: | C(C3(c1ccc(cc1)NC(c2cccc(c2)Cl)=O)CCC3)(NCCC)=O | InChi: | InChI=1S/C21H23ClN2O2/c1-2-13-23-20(26)21(11-4-12-21)16-7-9-18(10-8-16)24-19(25)15-5-3-6-17(22)14-15/h3,5-10,14H,2,4,11-13H2,1H3,(H,23,26)(H,24,25) | Definition date: | 2019-12-06 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide |
|
![JRE JRE](https://data.pdbj.org/pdbjplus/data/cc/svg/JRE.svg) | JRE | Name: | 6-[5-chloranyl-4-[(1~{S})-1-oxidanylethyl]pyridin-3-yl]-3,4-dihydro-2~{H}-1,8-naphthyridine-1-carboxamide | Formula: | C16 H17 Cl N4 O2 | SMILES: | C[CH](O)c1c(Cl)cncc1c2cnc3N(CCCc3c2)C(N)=O | InChi: | InChI=1S/C16H17ClN4O2/c1-9(22)14-12(7-19-8-13(14)17)11-5-10-3-2-4-21(16(18)23)15(10)20-6-11/h5-9,22H,2-4H2,1H3,(H2,18,23)/t9-/m0/s1 | Definition date: | 2019-03-21 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 6-[5-chloranyl-4-[(1~{S})-1-oxidanylethyl]pyridin-3-yl]-3,4-dihydro-2~{H}-1,8-naphthyridine-1-carboxamide |
|
![JTW JTW](https://data.pdbj.org/pdbjplus/data/cc/svg/JTW.svg) | JTW | Name: | 4-chloranyl-~{N}-(2-hydroxyethyl)-2-(phenylsulfonyl)-5-sulfamoyl-benzamide | Formula: | C15 H15 Cl N2 O6 S2 | SMILES: | N[S](=O)(=O)c1cc(C(=O)NCCO)c(cc1Cl)[S](=O)(=O)c2ccccc2 | InChi: | InChI=1S/C15H15ClN2O6S2/c16-12-9-13(25(21,22)10-4-2-1-3-5-10)11(15(20)18-6-7-19)8-14(12)26(17,23)24/h1-5,8-9,19H,6-7H2,(H,18,20)(H2,17,23,24) | Definition date: | 2019-03-27 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 4-chloranyl-~{N}-(2-hydroxyethyl)-2-(phenylsulfonyl)-5-sulfamoyl-benzamide |
|
![L4K L4K](https://data.pdbj.org/pdbjplus/data/cc/svg/L4K.svg) | L4K | Name: | 4-pentylbenzenesulfonamide | Formula: | C11 H17 N O2 S | SMILES: | CCCCCc1ccc(cc1)[S](N)(=O)=O | InChi: | InChI=1S/C11H17NO2S/c1-2-3-4-5-10-6-8-11(9-7-10)15(12,13)14/h6-9H,2-5H2,1H3,(H2,12,13,14) | Definition date: | 2019-07-21 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 4-pentylbenzenesulfonamide |
|
![JWQ JWQ](https://data.pdbj.org/pdbjplus/data/cc/svg/JWQ.svg) | JWQ | Name: | (~{E})-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)-~{N}-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide | Formula: | C14 H9 F3 N4 O3 S | SMILES: | COc1cc(ccc1O)C=C(C#N)C(=O)Nc2sc(nn2)C(F)(F)F | InChi: | InChI=1S/C14H9F3N4O3S/c1-24-10-5-7(2-3-9(10)22)4-8(6-18)11(23)19-13-21-20-12(25-13)14(15,16)17/h2-5,22H,1H3,(H,19,21,23)/b8-4+ | Definition date: | 2019-04-09 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)-~{N}-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide |
|
![JYZ JYZ](https://data.pdbj.org/pdbjplus/data/cc/svg/JYZ.svg) | JYZ | Name: | (~{E})-2-cyano-~{N}-(2-hydroxyphenyl)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C17 H14 N2 O4 | SMILES: | COc1cc(ccc1O)C=C(C#N)C(=O)Nc2ccccc2O | InChi: | InChI=1S/C17H14N2O4/c1-23-16-9-11(6-7-15(16)21)8-12(10-18)17(22)19-13-4-2-3-5-14(13)20/h2-9,20-21H,1H3,(H,19,22)/b12-8+ | Definition date: | 2019-04-11 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-2-cyano-~{N}-(2-hydroxyphenyl)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide |
|
![N8W N8W](https://data.pdbj.org/pdbjplus/data/cc/svg/N8W.svg) | N8W | Name: | ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide | Formula: | C9 H14 N2 O5 | SMILES: | CC(=O)N[CH]1CN2[CH](COC2=O)[CH](O)[CH]1O | InChi: | InChI=1S/C9H14N2O5/c1-4(12)10-5-2-11-6(3-16-9(11)15)8(14)7(5)13/h5-8,13-14H,2-3H2,1H3,(H,10,12)/t5-,6+,7+,8-/m0/s1 | Definition date: | 2019-11-15 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide |
|
![K0N K0N](https://data.pdbj.org/pdbjplus/data/cc/svg/K0N.svg) | K0N | Name: | (~{E})-~{N}-(5-~{tert}-butyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C17 H18 N4 O3 S | SMILES: | COc1cc(ccc1O)C=C(C#N)C(=O)Nc2sc(nn2)C(C)(C)C | InChi: | InChI=1S/C17H18N4O3S/c1-17(2,3)15-20-21-16(25-15)19-14(23)11(9-18)7-10-5-6-12(22)13(8-10)24-4/h5-8,22H,1-4H3,(H,19,21,23)/b11-7+ | Definition date: | 2019-04-11 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-~{N}-(5-~{tert}-butyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide |
|
![K0Z K0Z](https://data.pdbj.org/pdbjplus/data/cc/svg/K0Z.svg) | K0Z | Name: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C13 H9 Br N4 O3 S | SMILES: | COc1cc(ccc1O)C=C(C#N)C(=O)Nc2sc(Br)nn2 | InChi: | InChI=1S/C13H9BrN4O3S/c1-21-10-5-7(2-3-9(10)19)4-8(6-15)11(20)16-13-18-17-12(14)22-13/h2-5,19H,1H3,(H,16,18,20)/b8-4+ | Definition date: | 2019-04-14 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide |
|
![K1B K1B](https://data.pdbj.org/pdbjplus/data/cc/svg/K1B.svg) | K1B | Name: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-nitro-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C12 H6 Br N5 O4 S | SMILES: | Oc1ccc(C=C(C#N)C(=O)Nc2sc(Br)nn2)cc1[N+]([O-])=O | InChi: | InChI=1S/C12H6BrN5O4S/c13-11-16-17-12(23-11)15-10(20)7(5-14)3-6-1-2-9(19)8(4-6)18(21)22/h1-4,19H,(H,15,17,20)/b7-3+ | Definition date: | 2019-04-15 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-nitro-4-oxidanyl-phenyl)prop-2-enamide |
|
![MJD MJD](https://data.pdbj.org/pdbjplus/data/cc/svg/MJD.svg) | MJD | Name: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate | Formula: | C33 H42 F2 N4 O8 S | SMILES: | C12CC3COC1OCC2C3OC(=O)NC(Cc4cc(cc(c4)F)F)C(O)CN(CC(C)C)S(=O)(=O)c5cc6c(cc5)nc(o6)NC(C)C | InChi: | InChI=1S/C33H42F2N4O8S/c1-17(2)13-39(48(42,43)23-5-6-26-29(12-23)46-32(37-26)36-18(3)4)14-28(40)27(9-19-7-21(34)11-22(35)8-19)38-33(41)47-30-20-10-24-25(30)16-45-31(24)44-15-20/h5-8,11-12,17-18,20,24-25,27-28,30-31,40H,9-10,13-16H2,1-4H3,(H,36,37)(H,38,41)/t20-,24-,25-,27+,28-,30+,31+/m1/s1 | Definition date: | 2019-04-04 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate |
|
![R1V R1V](https://data.pdbj.org/pdbjplus/data/cc/svg/R1V.svg) | R1V | Name: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid | Formula: | C15 H25 N O4 | SMILES: | CC(C)=[C@H]CCC(C)=[C@H]CNC(C(O)=O)CCC(=O)O | InChi: | InChI=1S/C15H25NO4/c1-11(2)5-4-6-12(3)9-10-16-13(15(19)20)7-8-14(17)18/h5,9,13,16H,4,6-8,10H2,1-3H3,(H,17,18)(H,19,20)/b12-9+/t13-/m0/s1 | Definition date: | 2020-01-23 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid |
|
![O6Z O6Z](https://data.pdbj.org/pdbjplus/data/cc/svg/O6Z.svg) | O6Z | Name: | ~{N}-(1~{H}-indazol-5-yl)butane-1-sulfonamide | Formula: | C11 H15 N3 O2 S | SMILES: | CCCC[S](=O)(=O)Nc1ccc2[nH]ncc2c1 | InChi: | InChI=1S/C11H15N3O2S/c1-2-3-6-17(15,16)14-10-4-5-11-9(7-10)8-12-13-11/h4-5,7-8,14H,2-3,6H2,1H3,(H,12,13) | Definition date: | 2020-02-17 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | ~{N}-(1~{H}-indazol-5-yl)butane-1-sulfonamide |
|
![RGD RGD](https://data.pdbj.org/pdbjplus/data/cc/svg/RGD.svg) | RGD | Name: | cyclobutyl[(2S,3aS,6aS)-6a-(2-hydroxyethyl)-2-(hydroxymethyl)hexahydro-5H-furo[2,3-c]pyrrol-5-yl]methanone | Formula: | C14 H23 N O4 | SMILES: | C2(OC1(CCO)CN(CC1C2)C(C3CCC3)=O)CO | InChi: | InChI=1S/C14H23NO4/c16-5-4-14-9-15(13(18)10-2-1-3-10)7-11(14)6-12(8-17)19-14/h10-12,16-17H,1-9H2/t11-,12-,14+/m0/s1 | Definition date: | 2020-02-12 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | cyclobutyl[(2S,3aS,6aS)-6a-(2-hydroxyethyl)-2-(hydroxymethyl)hexahydro-5H-furo[2,3-c]pyrrol-5-yl]methanone |
|
![RGM RGM](https://data.pdbj.org/pdbjplus/data/cc/svg/RGM.svg) | RGM | Name: | (3aS,8S,9aS)-2-acetyl-10-methyl-2,3,6,8,9,9a-hexahydro-3a,8-epiminocyclohepta[1,2-c:4,5-c']dipyrrol-4(1H)-one | Formula: | C14 H17 N3 O2 | SMILES: | C1(=O)C43C(CC(c2cncc12)N3C)CN(C(C)=O)C4 | InChi: | InChI=1S/C14H17N3O2/c1-8(18)17-6-9-3-12-10-4-15-5-11(10)13(19)14(9,7-17)16(12)2/h4-5,9,12,15H,3,6-7H2,1-2H3/t9-,12-,14+/m0/s1 | Definition date: | 2020-02-12 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (3aS,8S,9aS)-2-acetyl-10-methyl-2,3,6,8,9,9a-hexahydro-3a,8-epiminocyclohepta[1,2-c:4,5-c']dipyrrol-4(1H)-one |
|